Edgewise Therapeutics
EWTX
178 hedge funds and large institutions have $1.56B invested in Edgewise Therapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 39 reducing their positions, and 41 closing their positions.
126% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 39
2.23% more ownership
Funds ownership: 110.64% → 112.87% (+2.2%)
7% less funds holding
Funds holding: 192 → 178 (-14)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
27% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 41
33% less call options, than puts
Call options by funds: $775K | Put options by funds: $1.15M
33% less capital invested
Capital invested by funds: $2.32B → $1.56B (-$764M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$39.7M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$25.2M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$21.1M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$19.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$16.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$30.8M |
| 2 |
PA
Perceptive Advisors
New York
|
-$27.5M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$10.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.58M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$7.95M |
EWTX Hedge Fund Activity: Q2 2025 in Review
178 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q2 2025, worth a combined $1.56B — down 33% from $2.32B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of EWTX and 30 opened new positions — a net loss of 11 holders — while 39 trimmed existing stakes and 88 added.
The largest buyer was Braidwell, adding an estimated $39.7M. The largest seller was Deep Track Capital, exiting entirely with an estimated $30.8M sold.
- 178 institutional investors held Edgewise Therapeutics (EWTX) as of Q2 2025, down from 192 in Q1 2025.
- Funds reported $1.56B of Edgewise Therapeutics stock for Q2 2025, down 33% quarter-over-quarter.
- 30 funds opened new Edgewise Therapeutics positions in Q2 2025 and 41 closed out, a net change of -11 holders.
- The largest Edgewise Therapeutics buyer in Q2 2025 was Braidwell, an estimated $39.7M added.
- The largest Edgewise Therapeutics seller in Q2 2025 was Deep Track Capital, an estimated $30.8M sold.
Based on aggregated 13F filings for Q2 2025.